Latest News
Braveheart Investment Group has chosen to partner with Seedrs to invest in early-stage businesses listed on its platform.
The partnership with Seedrs, one of the leading and most trusted equity crowdfunding platforms, will help to provide Braveheart with continuing deal flow in the coming months for the fund.
Braveheart had originally partnered with crowdfunding platform Crowdcube to launch the fund. However, Braveheart has now terminated its partnership with Crowdcube and decided to work with Seedrs.
Geoffrey Thomson, CEO, Braveheart Investment Group, says: “Seedrs is an outstanding platform with considerable investment expertise. Working with Seedrs will allow us to get exposure
Merger and acquisition activity has held up in the UK during the first quarter of 2015 despite the uncertainty created by the election, according to the latest PCPI/PEPI Index from BDO Corporate Finance.
The index, which tracks the multiples paid by trade and private equity buyers for private companies found that private equity buyers are paying more than the previous quarter – 10.9x up from 9.5x while trade buyers are paying less – 9.2x down from 11.7x. The disparity between multiples is explained by the relative growth profiles and size of transaction during the quarter – private equity tended to
London-listed private equity fund JZ Capital Partners has acquired SAC, an operational van leasing company based south of Copenhagen, Denmark.
Led by CEO Rene Ubbesen, who has been with SAC and its predecessor company for over 20 years, SAC’s business model is based on flexible short and long term leases with an average lease period of approximately four years. SAC controls the full life cycle of its product, including procurement, financing, service & warranty and resale.
JZCP acquired 45 per cent of SAC through its EuroMicrocap Fund for approximately EUR2.8 million. Furthermore, JZCP also acted as mezzanine lender, providing EUR4.8
GrafTech International has signed a letter of intent regarding the potential sale of USD150 million of 7 per cent convertible preferred shares in a private offering to an affiliate of alternative asset manager Brookfield Asset Management (BAM).
GrafTech has also entered into a separate letter of intent for a possible tender offer by Brookfield to acquire outstanding shares of GrafTech common stock.
The first letter of intent contemplates that the convertible preferred shares would be issued in two series. One series would be immediately convertible into common shares equal to up to 19.9 per cent of the currently outstanding shares
Private equity fundraising through the first quarter is examined in this extract from the Preqin Quarterly Update: Private Equity, Q1 2015.
Q1 2015 has seen a marked drop in the number of private equity funds closed, down from 324 in Q4 2014 to just 166 in the first quarter of the new year (Fig. 1). When compared with Q1 2014, the same downward trend is apparent, with 263 vehicles closed in the first quarter of 2014. However, despite a decline in number of funds, the level of aggregate capital raised has not fallen proportionally. Private equity vehicles closed in
Cathay Capital Private Equity has successfully completed an investment in Echosens, a subsidiary of the FuRui group.
Founded in 2001 in France, Echosens is a world-leading high-tech company specialising in non-invasive diagnostic products and services for hepatology. It produces FibroScan, which is an advanced medical device which carries out non-invasive and quantitative diagnosis to detect liver fibrosis and steatosis. This solution has been approved for sale in over 70 countries around the world.
Cathay Capital is leading a consortium, with two other strategic investors including OrbiMed Advisors, which is entering Echosens’ shareholding structure in the context of a capital
Law firm Eversheds has advised mid-market private equity firm CBPE Capital on the sale of IDIS Group Holdings to Clinigen Group for an Enterprise Value of GBP225m.
The transaction represents a money multiple of 22x CBPE’s GBP9.4m investment in IDIS.
IDIS is the global leader in providing regulatory and ethically compliant access to unlicensed medicines for healthcare professionals and their patients with unmet medical needs.
The Eversheds team was led by Partner and head of private equity Richard Moulton, assisted by Principal Associate Louise Finnie and Associate Andy Lord. Share options advice was provided by Partner Danny Blum and Associate
iTech Capital, a Europe-based Venture Capital fund with a focus on the global digital market, invested USD2 million for a minority stake in Clickky, a global mobile app marketing platform.
Clickky is a one-stop mobile app marketing platform which uses in-house proprietary technology to offer user acquisition, traffic monetisation and performance analysis. The platform boasts its own affiliate and offerwall advertising network with more than 10,000 traffic partners, DMP and media-buying technologies. Clickky runs campaigns for clients on multiple traffic sources to reach the whole mobile ecosystem, using in-house targeting and optimisation capabilities.
The investment by iTech Capital will
Livingstone’s Industrial sector team has advised Smiths Group, a global leader in applied advanced technologies, on the disposal of Specac Limited, a scientific instrumentation accessories business.
Members of the Specac executive team have partnered with Foresight Group to acquire the company.
Specac, based in Orpington, Kent, is a leading manufacturer of high specification sample analysis systems and sample preparation equipment for use in Life Sciences, Pharmaceutical, Environmental, Quality Control & Research laboratories around the world. The company’s products are primarily focused on supporting Infrared Spectroscopy, an important analytical technique prevalent in both research and commercial-industrial labs.
Having concluded that Specac
In the Bain & Co Global Healthcare Private Equity Report 2015, the prominence of early stage investments in the healthcare sector is a recurring theme, detailing how larger funds are continuing the trend of investing down market. Preqin’s Funds in Market online service tracks 99 early stage venture capital vehicles currently in market with a focus on the healthcare industry, either solely or as part of a wider industry focus; these funds are collectively targeting USD7 billion in commitments.
Early stage healthcare venture capital fundraising has undoubtedly been strong in recent years: 2014 saw the highest ever amount of capital
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
